KROS

Keros Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Seth AlpnaDirector
$28k2.6k shares
SellJun 4, 2026
$10.72
--
Bienaime Jean JacquesDirector
$11k1k shares
BuyMay 15, 2026
$10.58
--
Bienaime Jean JacquesDirector
$12k1k shares
BuyApr 15, 2026
$11.70
--
Bienaime Jean JacquesDirector
$22k2k shares
BuyMar 9, 2026
$11.21
--
Seehra JasbirDirector, Officer: CHIEF EXECUTIVE OFFICER
$113k7k shares
SellFeb 19, 2026
$16.17
--
Cho EstherSVP, General Counsel
$78k4.7k shares
SellFeb 18, 2026
$16.35
--

News

seekingalpha.comKeros Therapeutics, Inc. (KROS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 8globenewswire.comKeros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conferenceglobenewswire.comJun 1zacks.comShould You Buy KROS After Q1 Miss and Takeda Deal Reset?zacks.comMay 22zacks.comKROS Turns to Next Wave of TGF-Beta Muscle Therapieszacks.comMay 22zacks.comKROS Stock Guide to Rinvatercept in DMD and ALS for 2026zacks.comMay 22